Newsroom

News and safety alerts

868 items

Announcements, product safety communications and regulatory updates.

Safety Alert

Varenicline tartrate: Loss of consciousness

Overview Varenicline is used in smoking cessation treatment by relieving the craving and withdrawal symptoms associated with stopping smoking. It can also reduce the enjoyment of cigarettes if…

Safety Alert

Isoniazid: Risk of pancreatitis

Overview Isoniazid is an antibiotic used in the treatment of tuberculosis. It can be used alone (prevention) or in combination with other antituberculosis drugs (treatment). Pancreatitis is an…

Document attached

Safety Alert

Saccharomyces boulardii: Risk of fungaemia

Background: Saccharomyces boulardii is a live yeast used as a probiotic. Previously, Saccharomyces boulardii -containing products have been contraindicated in patients with central venous catheter…

Document attached

Announcement

What's new on NPRA new website

NPRA is proud to announce the launch of our new website which coincides with our mission to safeguard the nation's health through scientific excellence in the regulatory control of medicinal products…

Document attached

Safety Alert

Efavirenz: Risk of QTc interval prolongation

Overview Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that exhibits virological suppression, reducing the amount of virus in the body. Efavirenz is commonly used along with…

Document attached

Safety Alert

Methotrexate: Pulmonary alveolar haemorrhage

Overview Methotrexate is a disease-modifying anti-rheumatic drug (DMARD) and also an anti-neoplastic agent. The current registered indications of methotrexate include oncologic indications such as…

Safety Alert

Mesalazine: Risk of photosensitivity reactions

Overview Mesalazine, or 5-aminosalicylic acid (5-ASA), is an anti-inflammatory agent used in the management of inflammatory bowel diseases, such as ulcerative colitis and Crohn’s disease. It helps in…

Document attached

Announcement

Penipuan Kutipan Derma

Dimaklumkan bahawa terdapat individu tidak bertanggungjawab yang telah menggunakan nama NPRA untuk tujuan kutipan derma / sumbangan / tajaan NPRA tidak pernah memberi sokongan / bekerjasama dengan…

Safety Alert

Noradrenaline: Stress cardiomyopathy

Overview: Stress cardiomyopathy, also referred to as Takotsubo cardiomyopathy, is an acute condition associated with transient left ventricular dysfunction1. There are several clinical manifestations…

Document attached

Announcement

New Publication: MADRAC Bulletin - Issue 01/2018

MADRAC Bulletin - Issue 01/2018 Features ▪ Recent Safety Issues with Fluoroquinolones Articles based on Case Reports ▪ Simvastatin: Reminder on the Risk of Cognitive Impairment ▪ Dipeptidyl…

Document attached